Protherics PLC - Director/PDMR Shareholding
11 June 2008 - 1:42AM
Marketwired
Cheshire, UK , the international biopharmaceutical company
focused on critical care and cancer, Protherics PLC announces the
grant, on 9 June 2008, of the following options over Ordinary
Shares in Protherics ("Ordinary Shares") to Directors and other
Persons Discharging Managerial Responsibility (PDMRs) under the
terms of the Protherics PLC Long Term Incentive Plan ("LTIP"): Name
Position Number of Options Directors: Andrew Heath Chief Executive
Officer 500,000 Rolf Soderstrom Finance Director 313,513 James
Christie Operations Director 270,270 PDMRs: Ian Scoular Director of
Business Development 227,027 Nick Staples Director of Corporate
Affairs 191,891 Sally Waterman Director of Research &
Development 227,027 The options are exercisable between the third
and tenth anniversary of the date of grant at an exercise price of
2p per share, subject to the achievement of performance conditions.
Protherics also announces the award, on 9 June 2008, of a
conditional right to receive 252,460 Ordinary Shares under the
terms of the LTIP, to Saul Komisar, President of the Company's US
operations. The award vests on the third anniversary of the date of
grant subject to the achievement of performance conditions. In
addition to the above, the following Directors and PDMRs were
granted options under the terms of the Deferred Bonus Plan on 9
June 2008: Number of Directors: Options Rolf Soderstrom 99,099
James Christie 128,378 PDMRs: Sally Waterman 86,486 Nick Staples
72,972 The options are exercisable between the second and tenth
anniversary of the date of grant at an exercise price of 2p per
share. Following the above grant of options and share awards, the
Company's Directors and PDMRs hold options or share awards over the
following number of Ordinary Shares: Number of Shares Andrew Heath
4,523,909 Rolf Soderstrom 1,040,339 James Christie 1,851,986 Saul
Komisar 1,523,541 Ian Scoular 1,348,758 Nick Staples 871,114 Sally
Waterman 993,023 / Ends / For further information please contact:
Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919
480510 Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott
+44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212
850 5600 Or visit www.protherics.com This information is provided
by RNS The company news service from the London Stock Exchange
END
Contacts: RNS Customer Services 0044-207797-4400 Email Contact
http://www.rns.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Protherics (MM) (NASDAQ): 0 recent articles
More Protherics PLC News Articles